BHVN May 2024 40.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
At close: 03:50PM EDT
| Previous close | 2.9000 |
| Open | 0.0500 |
| Bid | 0.1000 |
| Ask | 0.4500 |
| Strike | 40.00 |
| Expiry date | 2024-05-17 |
| Day's range | 0.0500 - 0.8500 |
| Contract range | N/A |
| Volume | |
| Open interest | 500 |
PR NewswireBiohaven Reports First Quarter 2024 Financial Results and Recent Business Developments
Biohaven Ltd. (NYSE: BHVN) (Biohaven or the Company), a global clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of life-changing therapies to treat a broad range of rare and common diseases, today reported financial results for the first quarter ended March 31, 2024, and provided a review of recent accomplishments and anticipated upcoming developments.
Simply Wall St.Independent Director of Biohaven John Childs Buys 3.2% More Shares
Those following along with Biohaven Ltd. ( NYSE:BHVN ) will no doubt be intrigued by the recent purchase of shares by...
GuruFocus.comDirector Gregory Bailey Acquires 25,503 Shares of Biohaven Ltd (BHVN)
On April 24, 2024, Gregory Bailey, Director of Biohaven Ltd (NYSE:BHVN), purchased 25,503 shares of the company, as reported in a recent SEC Filing.
© 2024 Yahoo. All rights reserved.